SCHEMBL30124969

SCHEMBL30124969

N#Cc1ccc2ncnc(Cl)c2c1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 9/20 0.50
MAP4K4 O95819 2/20 0.50
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
CCNC P24863 2/20 0.48
CDK8 P49336 2/20 0.48
CDKN1A P38936 1/20 0.48
CDK19 Q9BWU1 1/20 0.48
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
PDE5A O76074 1/20 0.42
ABCG2 Q9UNQ0 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5766404 1.00 IRAK4 (0.50) IRAK4MAP4K4PDE4APDE4BPDE4C
SCHEMBL17680365 0.86 PDE4A (0.48) IRAK4MAP4K4PDE4APDE4BPDE4C
SCHEMBL3736219 0.83 MAP4K4 (0.71) IRAK4MAP4K4ALDH1A1CYP1A2CYP3A4
SCHEMBL22549000 0.79 IRAK4 (0.50) IRAK4MAP4K4CCNCCDK8CDKN1A
SCHEMBL17660499 0.79 MAP4K4 (0.77) IRAK4MAP4K4CCNCCDK8CDKN1A
SCHEMBL31362865 0.79 IRAK4 (0.50) IRAK4MAP4K4CCNCCDK8CDKN1A
SCHEMBL17203049 0.79 IRAK4 (0.50) IRAK4MAP4K4CCNCCDK8CDKN1A
SCHEMBL7505331 0.75 PIN1 (0.40) IRAK4CCNCCDK8CDKN1ACDK19
SCHEMBL730084 0.75 PDE5A (0.49) IRAK4MAP4K4CCNCCDK8CDKN1A
SCHEMBL30369707 0.75 PDE5A (0.49) IRAK4MAP4K4CCNCCDK8CDKN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4352061-A1 QUINAZOLINE DERIVATIVES USEFUL AS RAS INHIBITIORS Redx Pharma Plc (GB) 2024-04-17 EP disclosed
WO-2022258974-A1 QUINAZOLINE DERIVATIVES USEFUL AS RAS INHIBITIORS REDX PHARMA PLC (GB) 2022-12-15 WO disclosed